Company: CERO
Filing Date: 2025-05-02
Form Type: PRER14A
Source: 0001213900-25-039149
Chunk: 118

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-02
Form: PRER14A
Chunk 118
---
 stock splits, combinations and similar events, and, in the event of stock dividends and splits, the number of shares of Common Stock issuable upon the exercise of such warrant will also be adjusted so that the aggregate exercise price shall be the same immediately before and immediately after any such adjustment. However, unlike the Series A Warrants and Series C Warrants, the warrants issued on January 6, 2025 are not subject to any exercise price reduction or adjustment relating to the timing of shareholder approval thereof or the pricing of any future offering. Warrants Issued on February 7, 2025 On February 7, 2025, we issued and sold 300,000shares of our Common Stock and 2,251,020 Pre -FundedWarrants to purchase 2,251,020shares of our Common Stock together with 2,551,020 February 2025 Common Warrants to purchase 2,551,020shares of Common Stock. Each share of Common Stock or Pre -FundedWarrant is being sold together with a February 2025 Common Warrant to purchase one share of Common Stock. The shares of Common Stock or Pre -FundedWarrants and accompanying February 2025 Common Warrants were issued separately and were immediately separable upon. 66 (A) Pre-Funded Warrants The following summary of certain terms and provisions of the Pre -FundedWarrants is not complete and is subject to, and qualified in its entirety by, the provisions of the Pre -FundedWarrant, the form of which is filed as Exhibit No. 4.8 to the registration statement filed with the SEC on February 5, 2025. Prospective investors should carefully review the terms and provisions of the form of Pre -FundedWarrant for a complete description of the terms and conditions of the Pre -FundedWarrants. Duration and Exercise Price:Each Pre -FundedWarrant offered has an initial exercise price per share equal to $0.0001. The Pre -FundedWarrants are immediately exercisable and may be exercised at any time until the Pre -FundedWarrants are exercised in full. The exercise price and number of shares of Common Stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting our Common Stock and the exercise price. Exercisability:Each Pre -FundedWarrant may be exercised at any time following the date of issuance and from time to time thereafter